Cytopathology and Histopathology 2019

Cytopathology 2019 Conference

Cytopathology 2019 invites scholars, researchers, academicians, students and corporate entities across the globe to join at the 17^th International Conference on Cytopathology & Histopathology (Cytopathology-2019) to have a meaningful discussion with scholars during July 26-27, 2019 in Vancouver, Canada. The conference focuses on “Understanding the aetiology, diagnosis and management of diseases”.

Cytopathology 2019 anticipates participants all around the globe with thought-provoking Keynote lectures, Oral, Young Researcher Forum and Poster presentations with Exhibition. The attending delegates include Editorial Board Members of related Journals.

Successful completion of Cytopathology 2018, Conference Series LLC Ltd welcomes all to join the exclusive event Cytopathology 2019, Vancouver, USA and showcase the recent research in the tremendous field of Cytopathology-Histopathology among the experts.

Students are warmly welcome to attend or to present their research work as Poster presenter and Young Researcher forum in this prestigious profile Cytopathologists & Histopathologists.

Who is attending?

• Cytopathologists
• Cytotechnologists
• Histopathologists
• Pathologists
• Gynecologists
• Interns
• Residents
• Physicians, Surgeons, and Interventional Radiologists
• Medical Technologists
• Medical and Cytotechnology Students
• Researchers in Clinical Cytology

Benefits of Attending the Conference

• The Career Guidance Workshops to the Graduates, Doctorates and Post-Doctoral Fellows, Certificate Accreditation from the Organizing Committee of presentation/ participation.
• Accepted Abstracts will be published in the respective journals and will be labeled with a Digital Object Identification Number (DOI) provided by CrossRef (Free abstract publishing).
• Speaker and Abstract pages created in Google on your name would get worldwide acknowledgment to your profile and Research.
• Best Poster and Young Researcher Award.

Supporting Journals:

• Journal of Clinical & Experimental Pathology
• Journal of Cytology & Histology
• Journal of Anatomy & Physiology: Current Research

Contact Person:

Robert Johnson

Program Manager | Cytopathology 2019

Phone: 1-888-843-8169

Email: cytology@americameetings.net

Session Agenda

Cytopathology Congress one of the World's best platforms on Pathology events will enable to put forth the holistic scientific approach to validating existing and development of Cytopathologic and Histopathologic techniques as to better understanding of diseases and diagnosis. Cytopathology conference is set to witness an exhilarating sessions in scientific program which will focus on latest innovations in Cancer Cytopathology, Clinical & Molecular Cytopathology, Stem Cell Therapy & Anatomical Pathology, Diagnostic & Comprehensive Cytopathology, General Cytopathology & Immunocytochemistry, Cytopathology & Disease diagnosis, Forensic Cytopathology, Genome Expression Profiling, Gene therapy, Bacterial & Microbial pathology Infection control, Veterinary Cytopathology.

Cytopathology Meeting will be the platform for business delegates, B2B meetings, poster presentations, Cytopathology workshops, Cytopathology symposia and much more. Past conference of Cytopathology meeting in 2015, 2016, 2017, & 2018 has grounded the best possible researchers in the field of Cytopathology & Histopathology from diverse scientific disciplines and opened the channels for research funding opportunities and collaborations, and so will be upcoming.

Track 1: Cancer Cytopathology

Cytopathology usually used to aid in the diagnosis of cancer, but also helps in the diagnosis of certain infectious diseases and other inflammatory conditions. Cancer Cytopathology is generally used on samples of free cells or tissue fragments, in contrast to histopathology, which studies whole tissues. Cytopathologic tests are sometimes called smear tests because the samples may be smeared across a glass microscope slide for subsequent staining and microscopic examination. Gallbladder cancer is a relatively uncommon cancer and can be cure by fine needle aspiration material. However, cytology samples may be prepared in other ways, including cytocentrifugation. Different types of smear tests may also be used for cancer diagnosis. In this sense, it is termed a cytological smear. Epidemiology of Breast Cancer is the most commonly diagnosed cancer among women, with approximately 182,000 women diagnosed with breast cancer annually in the United States, accounting for approximately 26% of all incident cancers among women. Each year, 40,000 women die of breast cancer, making it the second-leading cause of cancer deaths among American women after lung cancer. The lifetime risk of dying of breast cancer is approximately 3.4%.

Track 2: Diagnostic Cytopathology

Diagnostic Cytopathology Essentials is a succinct yet comprehensive guide to diagnosis in both non-gynecological and gynecological cytology. It provides quick answers to diagnostic problems in the cytological interpretation and recognition of a wide range of disease entities. Diagnosis of Cancer is nearly always diagnosed by an expert who has looked at cell or tissue samples under a microscope. In some cases, tests done on the cells’ proteins, DNA, and RNA can help tell doctors if there’s cancer. These test results are very important when choosing the best treatment options. Fine needle aspiration cytology is an inexpensive, a traumatic technique for the diagnosis of disease sites. It illustrates how it may be applied to the management of tumors throughout the body. The limitations of the method, the dangers of false positive reports, and the inevitability of false negative diagnoses are emphasized. In a clinical context, the method has much to offer by saving patients from inappropriate operations and investigations and allowing surgeons to plan quickly and more rationally. It is an economically valuable technique and deserves greater recognition. Esophagus cancers are usually found because of signs or symptoms a person is having. If esophagus cancer is suspected, exams and tests will be needed to confirm the diagnosis. If cancer is found, further tests will be done to help determine the extent (stage) of cancer.

Track 3: Histopathology

Histopathology is the science or study dealing with the cytological and histologic structure of the abnormal or diseased tissue. Although it refers to the microscopic examination of tissue in order to study the manifestations of the disease. The study of tissues is called Tissue histology and is important to the understanding of how the human body is able to function as a unit. In clinical medicine, histopathology refers to the examination of a biopsy or surgical specimen by a pathologist, after the specimen has been processed and histological sections have been placed onto glass slides. In contrast, cytopathology examines free cells or tissue fragments. Immunohistochemistry (IHC) refers to the process of detecting antigens (e.g. proteins) in cells of a tissue section by exploiting the principle of antibodies binding specifically to antigens in biological tissues.

Histology, There are four basic types of tissues: muscle tissue, nervous tissue, connective tissue, and epithelial tissue. All tissue types are subtypes of these four basic tissue types (for example, blood cells are classified as connective tissue, since they generally originate inside bone marrow).

Histopathology, the microscopic study of diseased tissue, is an important tool in anatomical pathology since accurate diagnosis of cancer and other diseases usually requires histopathological samples.

Track 4: Exfoliative Cytopathology

Exfoliative Cytopathology is the most significant and time-consuming area of practice for most anatomical pathologists. Surgical pathology involves gross and microscopic examination of surgical specimens, as well as biopsies submitted by surgeons and non-surgeons such as general internists, medical subspecialists, dermatologists, and interventional radiologists.

Track 5: Cervical Cytopathology

Cervical cytology became the standard screening test for cervical cancer and premalignant cervical lesions. Cytologic examinations may be performed on body fluids (examples are blood, urine, and cerebrospinal fluid) or on material that is aspirated (drawn out via suction into a syringe) of the body. Cytology also can involve examinations of preparations that are scraped or washed (irrigated with a sterile solution) from specific areas of the body. For example, a common example of diagnostic cytology is the evaluation of cervical smears (referred to as the Papanicolaou test or Pap smear).

There are several methods to screen for cervical cancer. The Pap test (also known as Pap smear or conventional cytology) and liquid-based cytology are widely used throughout the world and have been credited with greatly reducing the number of cases and mortality from cervical cancer in the developed world. Cytology-based tests have not been as effective in developing countries, leading to an investigation of cervical screening approaches more suited to low-resource settings such as visual inspection with acetic acid or HPV DNA testing.

Track 6: Fine-needle aspiration Cytology

Fine-needle aspiration biopsy (FNAB, FNA or NAB), or fine-needle aspiration cytology (FNAC), is a diagnostic procedure used to investigate superficial (just under the skin) lumps or masses. In this technique, a thin, hollow needle is inserted into the mass for the sampling of cells that, after being stained, will be examined under a microscope. There could be a cytology exam of aspirate (cell specimen evaluation, FNAC) or histological (biopsy - tissue specimen evaluation, FNAB). Gene expression profiling is the measurement of the activity (the expression) of thousands of genes at once, to create a global picture of cellular function. These profiles can, for example, distinguish between cells that are actively dividing, or show how the cells react to a particular treatment. Many experiments of this sort measure an entire genome simultaneously, that is, every gene present in a particular cell. Fine-needle aspiration biopsies are very safe, minor surgical procedures. Often, a major surgical (excisional or open) biopsy can be avoided by performing a needle aspiration biopsy instead. In 1981, the first fine-needle aspiration biopsy in the United States was done at Maimonides Medical Center, eliminating the need for surgery and hospitalization. Today, this procedure is widely used in the diagnosis of cancer and inflammatory conditions. Gene expression the appearance in a phenotype of a characteristic or effect attributed to a particular gene. The process by which possession of a gene leads to the appearance of the phenotype of the corresponding character.

Track 7: Clinical & Molecular Cytopathology

Molecular Cytopathology is an emerging discipline within Cytopathology which is focused on the study and diagnosis of disease through the examination of molecules within organs, tissues or bodily fluids. Clinical pathology is a medical specialty that is concerned with the diagnosis of disease based on the laboratory analysis of bodily fluids, such as blood, urine, and tissue homogenates or extracts using the tools of chemistry, microbiology, hematology and molecular pathology. Cervical cancer is the third most common type of cancer among women worldwide. The infection and persistence of human papillomavirus (HPV) are the essential conditions for this type of disease. However, only HPV infection is not enough for cervical pathogenesis are necessary cofactors and activation of intracellular and extracellular mechanisms to start.

In the conventional Pap smear, the physician collecting the cells smears them on a microscope slide and applies a fixative. In general, the slide is sent to a laboratory for evaluation. The studies include Liquid-based monolayer cytology and Human papillomavirus testing. Diagnostic molecular pathology: Recent revolutionary progress in human genomics is reshaping our approach to therapy and diagnosis

Track 8: Cytopathology Case Reports

Cytopathology is the examination of cells from the body under the microscope to identify the signs and characteristics of the disease. Cytopathology is often loosely called "cytology," a word that simply means the study of cells.

A cytopathology report tells us whether the cells studied contain signs of disease. Cells examined for cytopathology can come from fluids extracted from body cavities - e.g. urine, sputum (spit), or fluids accumulating inside the chest or abdomen. Cells can also be extracted by inserting needles into lumps or diseased areas or tissues - called fine needle aspiration cytology (FNAC).

Laboratories may include recommendations as part of the Gynaecology Case reports. These may include a suggestion to the clinician for repeat cytology after a certain time interval or after treatment, or for tissue studies to further evaluate epithelial cell abnormalities.

Track 9: Veterinary Cytopathology

Veterinary Cytopathology is concerned with the diagnosis of disease based on the gross examination, microscopic, and molecular examination of organs, tissues, and whole bodies (necropsy). Veterinary pathologists are doctors of veterinary medicine who specialize in the diagnosis of diseases through the examination of animal tissue and body fluids. Other than the diagnosis of disease in food-producing animals, companion animals, zoo animals and wildlife, veterinary pathologists also have an important role in drug discovery and safety as well as scientific research. Veterinary Clinical Sciences is concerned with the diagnosis of disease based on the laboratory analysis of bodily fluids such as blood, urine or cavitary effusions, or tissue aspirates using the tools of chemistry, microbiology, hematology and molecular pathology.

The Treatment of Veterinary Diseases of veterinary diseases is possible with the Veterinary clinical science with the help of the diagnosis pattern. Among the four major geographies namely North America, Europe, Asia-Pacific and Rest of the world, European region is known to be a leading veterinary vaccine market in terms of consumption, closely followed by the U.S. These two regions collectively account for more than 70% of the global veterinary vaccine market revenue.

Track 10: Cytopathology & Disease diagnosis

 Cytology is a key component in the diagnosis and screening of diseases such as cancer. Cytology disease diagnosis assesses single cells and clusters of cells from sources such as malignant effusions and peripheral blood. Effusions are fluids that leak from blood and lymph vessels and aggregate in tissues and cavities within the body. This is a common problem in cancer patients and can be a reservoir of malignant cells. However, the total number of cells in effusions is small in comparison to the volumes of fluids that are produced. Therefore, in order to collect these cells for evaluation, they must be concentrated. Liver disease diagnosis can often be difficult to diagnose because its symptoms can be vague and easily confused with other health problems. In some cases, a person may have no symptoms at all but the liver may already have suffered significant damage.

Gynecologic cytology, also gynecologic cytopathology, is a field of pathology concerned with the investigation of disorders of the female genital tract. The most common investigation in this field is the Pap test, which is used to screen for potentially precancerous lesions of the cervix. Cytology can also be used to investigate disorders of the ovaries, uterus, vagina, and vulva.

Track 11: Urine Cytology

Cytology is the examination of cells from the body under a microscope. In a urine cytology exam, a doctor looks at cells collected from a urine specimen, to see how they look and function. The test commonly checks for infection, inflammatory disease of the urinary tract, cancer, or precancerous conditions. Urine cytology is better at finding larger and more aggressive cancers than small, slow-growing cancers.

VISA-TripAdvisor

Planning a Trip to Vancouver, Canada!!! Attending Meeting!!!

An issue with VISA!!

Cytopathology Committee will be happy to help you in all regards to plan your trip to Vancouver, Canada. Avail the official invitation letter from us to attend this event ahead with a closer step for approval of your VISA.

Find out what you need to do to visit Canada as a tourist or business person, how to extend your stay in Canada and what documents you need to carry with you to transit through Canada.

Application submission:

Canada does not have a visa office in every country so it is important that Delegates/Attendees visit the website of the visa office responsible for processing their visa applications.  Information is available on the website on how to submit a visa application and the documentation required. 

Delegates/Attendees are encouraged to submit their visa applications well in advance of the date of the event at a Visa Application Centre or on-line E-applications (e-Apps).

E-Apps

This system allows clients to submit applications online.

Delegates/Attendees that need a visa but require their passport for other travel purposes are strongly encouraged to submit their visa applications online (e-Apps).  Delegates/Attendees that choose to apply online will not have to submit their passport until a decision has been taken on their applications.  If required, the visa office will send the applicant instructions on how and where to send their passports to finalize the visa process.  

Visa Application Centres (VACs):

VACs are commercial service providers authorized by Canada to provide specific services to applicants. 

VACs provide a number of services including help applicants fill out forms, answer questions and ensure that applications are complete, thereby reducing unnecessary delays or refusals due to incomplete applications.

Applicants that are required to provide biometrics information as part of the visa application process can do so at a VAC.  Additional information on the biometrics requirements is available at the IRCC website.

VACs send applications to Visa Offices and transmit decisions to applicants in a secure and confidential manner. VACs do not process visa applications and play no role in the decision-making process.

Visa Applications Processing Time:

Processing time for visa applications vary depending on the office and the time of the year.  Participants should be encouraged to apply early for their visas, and to submit complete applications including all supporting documents.  

Please visit the IRCC website for information on the time it takes to process visa applications at the various visa offices. 

NEW - Electronic Travel Authorization (eTA)

As of March 15, 2016, visa-exempt foreign nationals are expected to have an Electronic Travel Authorization (eTA) to fly to or transit through Canada. Exceptions include U.S. citizens and travelers with a valid Canadian visa. Canadian citizens, including dual citizens, and Canadian permanent residents are not eligible to apply for an eTA.

However, from March 15, 2016, until fall 2016, travellers who do not have an eTA can board their flight, as long as they have appropriate travel documents, such as a valid passport. During this time, border services officers can let travellers arriving without an eTA into the country, as long as they meet the other requirements to enter Canada. We invite you to consult the IRCC website regularly for information updates on eTA.

Best Tourist Destination: Vancouver

• Stanley Park
• Granville Island
• Grouse Mountain
• Museum of Anthropology
• Kitsilano Beach
• Gastown
• Canada Place
• Chinatown
• English Bay
• Capilano Suspension Bridge
• Robson Street
• Museum of Vancouver
• Queen Elizabeth Park
• Science World
• Richmond & Many more…

For more help Mail Us: cytology@americameetings.net

Importants Date and Benefits

1st round of abstract submission: December 29th, 2018

2nd round of abstract submission: March 30th, 2019

3rd round of abstract submission: June 24th, 2019

Avail early bird registration benefits on or before: January 30th, 2019

Avail group participation discounts on more than 4 participants

The time duration for each category:

Keynote Speech: 40-45 minutes

Oral/ Plenary Speech: 30-35 minutes

Workshop: 60 minutes

 Participation Benefits:

• All accepted abstracts will be published in the respective supporting Journals
• Each abstract will receive a (DOI) Number provided by CrossRef
• All attendees will receive individual certification.
• Special privileges on group registrations.
• Networking with Experts in the Field
• Live Streaming of your presentation through our websites and YouTube
• Best Poster Competitions and Young Researcher Competitions
• The Career Guidance Workshops to the Graduates, Doctorates and Post-Doctoral Fellows
• Chance of B2B meeting
• Opportunity to organize Workshop/Symposia
• Opportunity to collaborate with our event
• Avail the opportunity to organize pre-conference workshop
• Individual momentos will be given to the Organizing Committee Members.
• Appreciation momentos will be awarded to the keynote speakers.
• Opportunity to interact with eminent personalities from all around the globe
• Handbook and conference kit

Past Conference Report

Cytopathology 2018

4th International Conference on Cytopathology and Histopathology organized during August 29-30, 2018 in Boston, USA. With the support and contribution of the Organizing Committee Members, we successfully hosted the event at the conference venue.

Firstly we must thank you for participating at Cytopathology 2018, a global platform to discuss various important aspects of pathology.

There are infinite reasons to extend our gratitude to you for making the Cytopathology 2018 outstanding conference. We couldn't have done it without your continuous support and believe towards our organization, which mutually made to achieve Cytopathology 2018 a new height in the field of Cytopathology and Histopathology Research.

The conference was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 20 countries, who have driven this event into the path of success.   

The conference was organized around the theme “Innovation and future trends of Cytopathology”. The event implanted a firm relation of upcoming strategies in the field of cytopathology and histopathology research with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures of which the following Speakers were highlighted as Keynote speakers:

• Vinod B. Shidham, Wayne State University School of Medicine, USA.
• Hamed A. Benghuzzi, University of Mississippi, USA. 
• Noeme Sousa Rocha, University of Sao Paulo, Brazil.
• Ke Cheng, HistoWiz, USA.
• Shunyou Gong, Northernwestern University, USA

The conference witnessed an amalgamation of peerless speakers, Keynote speakers, well-known researchers and delegates who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of cytopathology and histopathology through their fabulous presentations at the podium of Cytopathology 2018.    

Conference Series LLC Ltd offers its heartfelt appreciation to all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students and Editorial Board Members of International Journal of Cytology & Histology who supported the conference in every aspect for the awe-inspiring exhibition at the venue.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members.

So as a continuation of Cytopathology 2019, we would like to heartily invite you to our upcoming 5th International Conference on Cytopathology and Histopathology scheduled at Vancouver, Canada. We look forward to seeing your benign presence with active contribution and support to make this event successful once more.

Contact for more details:

Robert Johnson

Program Manager | Cytopathology 2018

E-Mail: cytology@americameetings.net